Gene Query: DR1

Dataset Description Geneva Score
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 108.79
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 39.37
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 35.43
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 34.98
RNAseq of HEK293 cells after Chtop knockdown 24.3
Co-transcriptional loading of RNA export factors shapes the human transcriptome 24.3
MULTI-seq: Universal sample multiplexing for single-cell RNA sequencing using lipid-tagged indices 23.01
Transcriptomic analysis of LSD1 22.84
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 22.61
Human cell line and subcutaneous tumor 21.52
Altering cancer transcriptomes using epigenomic inhibitors 21.12
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 21.12
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 19.85
Ribosomal footprinting of CN34-Parental and CN34-LM1a 19.78
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 19.24
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 18.89
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 18.25
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 18.25
Ribosomal footprinting of MDA-Parental and MDA-LM2 17.96
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 17.55
Identifying the molecular mode of action of itraconazole in colorectal cancer 16.13
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 16.06
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 15.88
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 15.27
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 15.17
Transcriptomic analysis of human tonsillar TFH subsets 15.12
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 15.11
Knockdown of ADNP in HCT116 colon cancer cells 14.93
Identification of Nrf2 regulated genes by RNA sequencing 14.71
Nrf2 regulated genes in A549 cells 14.71
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 14.24
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 14.16
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 14.11
Next generation sequencing identifies discrete classes of box C/D snoRNAs featuring different ends and RNA binding protein dependency 14.02
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 13.85
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 13.73
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 12.87
SLAM-seq for K562 endogenous mRNA decay 12.63
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 12.53
TGF-β regulation of miRNA expression in pancreatic cancer 12.42
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 12.39
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 12.25
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 12.13
MYC dependent mRNA translation shapes gene expression and cell biology 12.0
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 11.99
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 11.87
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 11.87
Targeting MTHFD2 in Acute Myeloid Leukemia 11.72
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 11.54
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 11.54
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 11.28
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 11.24
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 11.16
Effect of mitochondria deficiency on senescence-associated gene expression 11.15
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 11.03
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 10.92
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 10.76
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 10.7
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 10.69
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 10.66
Genome wide miR-191 target profile determined by RIP and gene expression profiling 10.63
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 10.63
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 10.62
SUV420H2 knockdown in PANC-1 10.48
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 10.43
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 10.37
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 10.34
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 10.32
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 10.3
Integrating single-cell transcriptomic data across different conditions, technologies, and species 10.14
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 10.08
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 10.08
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 10.06
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 9.87
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 9.83
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 9.78
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 9.71
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 9.39
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 9.39
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 9.35
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 9.29
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 9.25
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 9.24
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 9.24
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 9.16
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 9.11
RNA-Seq with and without RNase treatment in PCa cell lines 9.07
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 9.07
Sensing self and nonself circular RNAs 9.03
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 8.99
miR941 overexpression experiment 8.87
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 8.82
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 8.82
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 8.8
CROP-Seq in Primary Human T Cells 8.72
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 8.65
Systematic discovery of endogenous human ribonucleoprotein complexes 8.6
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 8.6
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 8.51
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 8.47
Mammalian Hbs1L deficiency causes Pelota depletion and is associated with a unique phenotype 8.46
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 8.42
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 8.41
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 8.35
Genetic regulation of human adipose microRNA expression and its consequences for metabolic traits 8.34
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 8.34
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 8.31
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 8.31
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 8.3
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 8.26
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 8.26
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 8.24
hnRNP C is a key regulator of protein synthesis in mitosis 8.21
RNA expression analysis upon JMJD1C depletion 8.21
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 8.21
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 8.18
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 8.08
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 8.05
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 8.05
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 7.98
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 7.96
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 7.92
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 7.9
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 7.89
Molecular Mechanisms of Endothelial Hyperpermeability 7.86
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 7.83
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 7.83
RNA-seq of RKO cells with cTAZ KO or putback 7.82
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 7.72
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 7.68
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 7.65
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 7.65
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 7.58
Solid phase chemistry to covalently and reversibly capture thiolated RNA 7.53
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 7.53
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 7.53
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 7.52
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 7.49
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 7.49
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 7.47
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 7.44
Transcriptome analysis of kidney organoids 7.44
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 7.41
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 7.36
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 7.36
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 7.29
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 7.29
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 7.21
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 7.14
Active translatome profiling with RiboLace in MCF7 cells 7.13
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 7.1
MYCL and EP400 are required for Max and MCPyV mediated gene activation 7.07
Biological effect of chronic mistranslation in mammalian cells 7.06
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 7.06
Effect of PBK knockdown on C4-2 cell transcriptome 6.97
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 6.97
SLIGRL-induced gene expression changes in NHEK cells 6.86
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 6.86
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 6.85
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 6.82
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 6.77
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 6.77
Cleavage Factor Im as a key regulator of 3’ UTR length 6.74
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 6.71
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 6.7
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 6.69
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 6.68
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 6.68
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 6.64
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 6.63
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 6.62
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 6.62
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 6.61
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 6.61
ETV7 and interferon response 6.59
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 6.59
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 6.58
Seletive inhibition of CDK9 in DLBCL cell lines 6.56
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 6.56
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 6.56
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 6.51
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 6.5
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 6.5
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 6.48
NHLRC1 re-expression in cancer cells 6.46
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 6.46
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 6.41
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 6.41
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 6.41
Determination of tRNA aminoacylation levels by high throughput sequencing 6.4
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 6.4
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 6.39
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 6.39
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 6.38
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 6.37
HNRNPL and its RNA Targets in Prostate Cancer 6.37
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 6.35
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 6.32
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 6.28
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 6.28
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 6.26
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 6.26
Spliceosomal disruption of the non-canonical BAF complex in cancer 6.25
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 6.25
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 6.21
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 6.21
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 6.21
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 6.15
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 6.14
snRNAs as regulators of alternative splicing 6.13
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 6.12
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 6.07
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 6.04
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 6.0
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 5.97
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 5.97
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 5.96
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 5.96
Conservative alteration of chromosomal expression pattern across human solid tumor types 5.96
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 5.94
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 5.93
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 5.92
Gene expression changes caused by KRAS in MCF-10A 5.89
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 5.88
Differential Protein Occupancy Profiling of the mRNA Transcriptome 5.84
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 5.8
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 5.79
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 5.77
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 5.77
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 5.71
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 5.68
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 5.67
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 5.59
STRIPAK directs PP2A activity to promote oncogenic transformation 5.56
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 5.54
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 5.52
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 5.5
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 5.45
Effect of drugs on transcriptomic profiles 5.43
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 5.41
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 5.39
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 5.28
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 5.27
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 5.23
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 5.23
Global Mapping of Human RNA-RNA Interactions 5.13
The transcriptomic landscape of MAIT cell development in the thymus (C006 RNAseq data set) 5.12
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 5.09
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 5.09
Regulation of protein translation during mitosis 5.08
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 5.08
Anti-inflammatory effect of indoleacrylic acid (IA) 5.05
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 5.05
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 5.02
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 4.97
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 4.95
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 4.88
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 4.79
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 4.79
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 4.77
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 4.77
The Genetic Landscape of Diamond-Blackfan Anemia 4.76
Comparative Analysis of Cas9 Activators Across Multiple Species 4.76
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 4.76
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 4.73
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 4.72
K562 polyA RNA-Seq 4.71
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 4.71
Transciptomic profiling of human fetal lung samples 4.67
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 4.65
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 4.62
O-glcnAc reprograms cellular energetics 4.61
RNA-Sequencing of HepG2 cells treated with TGFBeta 4.56
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 4.53
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 4.52
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 4.51
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 4.51
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 4.5
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 4.5
Capturing the Interactome of Newly Transcribed RNA 4.49
Capturing the Interactome of Newly Transcribed RNA (RICK) 4.49
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 4.49
Transcriptome profiling of 5 human adenocarcinoma cell lines 4.48
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 4.45
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 4.45
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 4.45
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 4.41
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 4.39
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 4.37
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 4.37
4sU-seq of HFF exposed to salt and heat stress 4.36
HBEC-shp53-PCHD7 4.26
RNA transcriptome analysis during HSV-1 infection 4.22
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 4.2
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 4.19
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 4.19
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 4.19
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 4.19
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 4.18
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 4.16
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 4.11
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 4.02
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 3.96
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 3.9
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 3.88
Role of COP1 on MAP kinase transcriptional output in melanoma 3.88
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 3.83
m6A-dependent regulation of messenger RNA stability 3.82
Transcriptome landscape of HeLa response upon triamcinolone acetonide 3.81
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 3.8
Human cells contain natural double-stranded RNAs with potential regulatory capacity 3.77
RNA-seq of MDA-MB-231 cells with TET1 knockout 3.75
MicroRNA-125a-5p overexpression in human macrophages 3.74
Novel Transcriptional Activity and Extensive Allelic Imbalance in the Human MHC Region 3.74
Mitochondrial dsRNA triggers antiviral signalling in humans 3.73
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 3.7
DRB/GRO-Seq -/+ UV 3.69
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 3.68
Transcriptomic analysis of ERR alpha orphan nuclear receptor 3.61
Defective structural RNA processing in relapsing-remitting multiple sclerosis 3.61
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 3.57
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 3.57
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 3.54
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 3.53
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 3.52
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 3.52
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 3.45
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 3.42
Gene expression profile in breast cancer cells 3.41
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 3.41
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 3.37
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 3.37
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 3.35
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 3.34
Triple vectors expand AAV transfer capacity in the retina 3.31
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 3.22
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 3.2
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 3.2
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 3.2
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 3.2
Novel Targeting of Transcription and Metabolism in Glioblastoma 3.19
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 3.17
Virus Mimicry in the Tumor Microenvironment Activates RIG-I Through Unshielding of Endogenous RNA in Exosomes [RNA-Seq] 3.15
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 3.15
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 3.12
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells 3.07
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 3.04
Transcriptome analysis of peripheral blood monocytes 3.01
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 2.99
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 2.99
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 2.98
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 2.94
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 2.93
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 2.75
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 2.75
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 2.72
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 2.72
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 2.61
IMP3 regulated gene expression in breast cancer cells 2.61
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 2.6
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 2.58
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription [RNA-Seq] 2.54
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription 2.54
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 2.53
RNA polymerase in pre-B-ALL cell lines 2.46
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 2.43
Exogenous rescue of KLHL9 in SF210 cell line 2.42
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 2.41
A code of mono-phosphorylation modulates the function of RB. 2.39
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 2.38
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 2.38
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 2.36
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 2.36
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 2.27
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 2.26
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 2.23
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 2.23
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 2.19
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 2.19
The transcriptome effect of overexpressing EZH2 in MCF7 2.09
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 2.09
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 2.09
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 2.08
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 2.06
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 2.05
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 2.04
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 2.01
Transcriptional landscape changes during human embryonic stem cell derivation 1.99
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 1.99
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 1.97
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 1.95
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 1.93
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 1.93
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 1.91
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 1.9
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 1.86
Aging-associated patterns in the expression of human endogenous retroviruses 1.83
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 1.82
Frailty in middle age is associated with race-specific changes to the transcriptome. 1.71
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 1.68
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 1.62
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 1.61
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 1.58
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 1.58
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 1.55
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 1.54
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 1.54
Silencing SPIB in attached and floating state of H1703 lung cancer cells 1.53
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 1.52
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 1.51
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 1.51
mRNA expression in human DAOY cells 1.48
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 1.45
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 1.44
Copper Regulation of HIF-1 Transcription Activity 1.43
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 1.43
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 1.43
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 1.4
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 1.36
tRNA modification landscape selectively controls mitochondrial translation efficiency in MERRF 1.34
4sUDRB-seq: measuring transcription elongation and initiation genomewide 1.32
Dermal endothelial cells of type 2 diabetic patients 1.32
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 1.3
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 1.3
Transposon-based construction of strand-specific RNA-seq libraries 1.27
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 1.25
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 1.22
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 1.18
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 1.17
naive T cell heterogeneity after neonatal thymectomy 1.14
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 1.1
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 1.07
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 1.05
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 0.96
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 0.96
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 0.89
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.89
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.89
RNA expression profiles comparing primary and omental ovarian carcinoma samples 0.88
Myc activation coordinates gene transcription and protein translation responses 0.87
Interphase condensins regulate ligand-depedent enhancer activation 0.86
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 0.86
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 0.85
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 0.85
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.82
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.82
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.78
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 0.77
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 0.77
Regulating Interleukin-2 activity with engineered receptor signaling clamps 0.76
mRNA recovered upon RNF219 IP. [RNA-IP] 0.75
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 0.75
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 0.74
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 0.69
A single-cell transcriptome atlas of the human pancreas 0.67
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 0.64
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 0.63
6mer seed toxicity in viral microRNAs 0.63
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 0.62
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 0.6
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 0.58
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 0.55
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 0.53
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 0.53
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 0.49
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 0.48
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 0.48
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.47
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.47
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.47
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 0.44
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.42
Modulation of nonsense-mediated decay by rapamycin 0.41
Transcriptome-wide modulation of splicing by the exon junction complex 0.4
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 0.4
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 0.37
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 0.36
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 0.36
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 0.36
RNA sequencing with KSHV infection and enrichment for circular RNAs 0.33
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.3
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells 0.24
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) 0.24
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.19
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.19
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.19
Next generation sequencing of small RNAs isolated from exosomes in human semen 0.16
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 0.15
HEXIM1 is induced by DHODH inhibition to suppress melanoma 0.15
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 0.09
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 0.09
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.08
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.07
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.05
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 0.04
Function and hormonal regulation of GATA3 in human first trimester placentation 0.03
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.03
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.02
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.01
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation